PATENT CLAIM ANALYSIS

Application Number: 15865378
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["424", "009340"]

Abstract:
Provided are novel human α-synuclein-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for α-synuclein are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for α-synuclein targeted immunotherapy and diagnosis, respectively.

Claim (Index 45):
A method for in vivo detection of \u03b1-synuclein in a human subject, the method comprising administering to the human subject a composition comprising the antibody or antigen-binding fragment thereof of  claim 41 , wherein \u03b1-synuclein is detected by positron emission tomography (PET), single photon emission tomography (SPECT), near infrared (NIR) optical imaging, magnetic resonance imaging (MM), or a combination thereof.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 86.0
- Lexical Diversity: 1.59574
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13140699', '15005948', '15410128', '14128497', '14654176']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8260352809807257
- 35 USC 102 Novelty (BERT): 0.6625494942681279
- Combined Prediction Score: 0.8096867023094658
- Mean Citation Score: 618.1686000000002
- Max Citation Score: 696.7445
- Similarity Product: 626.1140310104488

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test